dc.identifier.citation | Galluzzi L, Aaronson SA, Abrams J, Alnemri ES, Andrews DW, Baehrecke EH, Bazan NG, Blagosklonny MV, Blomgren K, Borner C, Bredesen DE, Brenner C, Castedo M, Cidlowski JA, Ciechanover A, Cohen GM, De Laurenzi V, De Maria R, Deshmukh M, Dynlacht BD, El-Deiry WS, Flavell RA, Fulda S, Garrido C, Golstein P, Gougeon ML, Green DR, Gronemeyer H, Hajnóczky G, Hardwick JM, Hengartner MO, Ichijo H, Jäättelä M, Kepp O, Kimchi A, Klionsky DJ, Knight RA, Kornbluth S, Kumar S, Levine B, Lipton SA, Lugli E, Madeo F, Malomi W, Marine JC, Martin SJ, Medema JP, Mehlen P, Melino G, Moll UM, Morselli E, Nagata S, Nicholson DW, Nicotera P, Nuñez G, Oren M, Penninger J, Pervaiz S, Peter ME, Piacentini M, Prehn JH, Puthalakath H, Rabinovich GA, Rizzuto R, Rodrigues CM, Rubinsztein DC, Rudel T, Scorrano L, Simon HU, Steller H, Tschopp J, Tsujimoto Y, Vandenabeele P, Vitale I, Vousden KH, Youle RJ, Yuan J, Zhivotovsky B, Kroemer G, Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes., Cell death and differentiation, 16, 8, 2009, 1093-1107 | en |
dc.description.abstract | Cell death is essential for a plethora of physiological processes, and its deregulation characterizes
numerous human diseases. Thus, the in-depth investigation of cell death and its mechanisms
constitutes a formidable challenge for fundamental and applied biomedical research, and has
tremendous implications for the development of novel therapeutic strategies. It is, therefore, of utmost
importance to standardize the experimental procedures that identify dying and dead cells in cell
cultures and/or in tissues, from model organisms and/or humans, in healthy and/or pathological
scenarios. Thus far, dozens of methods have been proposed to quantify cell death-related parameters.
However, no guidelines exist regarding their use and interpretation, and nobody has thoroughly
annotated the experimental settings for which each of these techniques is most appropriate. Here, we
provide a nonexhaustive comparison of methods to detect cell death with apoptotic or nonapoptotic
morphologies, their advantages and pitfalls. These guidelines are intended for investigators who
study cell death, as well as for reviewers who need to constructively critique scientific reports that
deal with cellular demise. Given the difficulties in determining the exact number of cells that have
passed the point-of-no-return of the signaling cascades leading to cell death, we emphasize the
importance of performing multiple, methodologically unrelated assays to quantify dying and dead
cells. | en |
dc.description.sponsorship | We declare no conflicting financial interests. This work was supported by a special grant from Ligue Nationale contre
le Cancer (LNC), as well as grants by Agence Nationale de Recherche (ANR), Agence Nationale de Recherches sur
le SIDA (ANRS), Institut National du Cancer (INCa), Canceropole Ilede-France, Fondation pour la Recherche
Medicale (FRM), Sidaction (to GK) and the European Commission (Active p53, Apo-Sys, ApopTrain, DeathTrain,
TransDeath, RIGHT). This work was supported by the NIH intramural program. SAA, JA, EA, EHB, NGB, MVB,
DEB, JAC, MD, BDD, WSE, RAF, DRG, GH, JMH, DJK, SK, BL, SAL, EL, UMM,GN, MEP, HS, RJY and JY are
supported by the National Institute of Health (NIH). HP is funded by the National Health and Medical Research Council
(NHMRC). OK is the recipient of an EMBO Ph.D. fellowship. EM is funded by an ApopTrain Ph.D. student fellowship.
DCR is a Wellcome Trust Senior Clinical Fellow. | en |